ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
Home
Press release
Jan 16, 2021 00:26 JST
Source:
Jacobson Pharma Corporation Limited
雅各臣建議分拆健倍苗苗(保健)有限公司於香港聯合交易所有限公司主板獨立上市
宣佈分派有條件特別中期股息
香港, Jan 15, 2021 - (ACN Newswire) - 於香港從事非專利藥及品牌藥品研發、生產、市場推廣及銷售的領先企業─雅各臣科研製藥有限公司(「雅各臣」或「集團」;股份代號:2633)今天公佈以有條件特別中期股息形式向合資格股東宣派合共241,777,625股健倍苗苗實物股份,佔緊隨建議分拆完成後健倍苗苗已發行股份總數約27.1%。
截止今天,雅各臣已發行股份(「股份」)總數為1,934,221,000股。假設自今天起至2021年1月29日 (「記錄日期」) 止股份總數並無變動,合資格股東將就於記錄日期每持有8股股份獲分派1股健倍苗苗股份。
分派須待公開發售於各方面成為無條件後方會作出。倘該條件未達成,則建議分拆將不會發生,而分派亦將 不會作出。
更多詳情請瀏覽公告:
https://www1.hkexnews.hk/listedco/listconews/sehk/2021/0115/2021011501334_c.pdf
關於雅各臣科研製藥有限公司(股份代號:2633)
雅各臣是香港領先非專利藥公司。旗下擁有並營運一系列品牌,主要包括「保濟丸」、「何濟公止痛退熱散」、「秀碧除疤膏」、「飛鷹活絡油」、「唐太宗活絡油」、「兜安氏藥膏」、「十靈丹」、「十靈油」及「傷風克」。為了策略性地擴展其品牌保健護理業務平台,除於海外市場代理知名品牌如「恢甲清」和「胃仙U」外,集團亦推出多個與健康和保健有關品牌及產品,例如「Dr. Freeman醫臣®流感/呼吸道合胞病毒家用式診斷套件」、「Smartfish健康營養產品」、「Dr. Freeman醫臣®感染控制產品系列」及「Dr. Freeman醫臣®COVID-19快速測試套件」亦於市場內大受歡迎。
同時,集團一直致力透過增加各種高增值產品,策略性地擴大其非專利藥和品牌保健護理業務的產品組合。扎根香港,集團已於中國、澳門、台灣、新加坡及柬埔寨開設營運子公司,建立區域性商業平台,以把握亞太區及大中華地區的市場潛力。而自 2017 年 6月 1 日,集團獲納入 MSCI 香港微型股指數成份股。更多詳情請瀏覽雅各臣科研製藥有限公司網站:
http://www.jacobsonpharma.com/
傳媒查詢:
縱橫財經公關顧問有限公司
李惠兒 電話: (852) 2864 4834 電郵:
vicky.lee@sprg.com.hk
高文萱 電話: (852) 2114 2370 電郵:
rachel.ko@sprg.com.hk
黃靖雯 電話: (852) 2114 4900 電郵:
mandy.wong@sprg.com.hk
傳真: (852) 2527 1196
Source: Jacobson Pharma Corporation Limited
Sectors: Daily Finance, Daily News, Healthcare & Pharm
Copyright ©2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
Latest Release
Mitsubishi Shipbuilding Receives Order from the University of Tokyo for "MiPoLin" Power Prediction and Lines Selection System
Mar 28, 2024 16:45 JST
Mitsubishi Logisnext Completes Demonstration of Automated Truck Loading, Leading to Start of Actual Operations in Japan
Mar 28, 2024 13:52 JST
Toyota Releases Sales, Production, and Export Results for February 2024
Mar 28, 2024 13:35 JST
TANAKA to Install 500 kW Fuel Cell System to Promote the Use of Hydrogen Energy at Production Plants
Mar 28, 2024 03:00 JST
PEVE to change name to TOYOTA BATTERY Co., Ltd. and produce batteries for a wide range of electric vehicles
Mar 27, 2024 15:13 JST
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy System
Mar 27, 2024 15:00 JST
TANAKA Holdings Announces Green Loan Financing for Construction of New Head Office Building
Mar 27, 2024 03:00 JST
JFE Steel and Hitachi Jointly Started Providing Solutions for the Steel Industry
Mar 26, 2024 19:04 JST
La Banque Postale and JCB join forces to elevate payments experience for travellers in France
Mar 26, 2024 15:00 JST
Fujitsu Tech Leverages AI and Underwater Drone Data for 'Ocean Digital Twin'
Mar 26, 2024 10:24 JST
NEC develops marketing strategy planning & effectiveness simulation technology using generative AI
Mar 25, 2024 10:08 JST
Toyota to Open New Tokyo Head Office in Shinagawa in FY2030
Mar 22, 2024 16:15 JST
Hitachi Selected as CDP Supplier Engagement Leader for the Third Consecutive Year
Mar 22, 2024 16:04 JST
Mitsubishi Motors Celebrates Production of 100,000th fully electric minivehicle
Mar 22, 2024 15:34 JST
JCB and AEON Credit Service Indonesia Launch the AEON JCB Precious Card
Mar 22, 2024 15:00 JST
JCB Issues White Paper on Calculating CO2 Emissions by Payment Method in Japan
Mar 22, 2024 12:00 JST
NEC and NTT successfully conduct first-of-its-kind long-distance transmission experiment over 7,000km using 12-core optical fiber
Mar 22, 2024 08:38 JST
Lifenet and Eisai Co-Develop Dementia Insurance "be"
Mar 21, 2024 17:36 JST
Toyota: Clarification of the Roles of and Expectations for Outside Executives, Revision of the Independence Assessment Criteria, and the Changes to Members of the Board of Directors and the Audit and Supervisory Board Members following the 120th Ordinary General Shareholders' Meeting
Mar 21, 2024 16:47 JST
Sales of Evolved GR Yaris to Start in April, While Purchasing Lotteries for WRC Driver-supervised Special Editions Start Today
Mar 21, 2024 16:31 JST
More Latest Release >>
Related Release
Jacobson Pharma Announces FY2023 Interim Results
November 25 2022 21:21 JST
Jacobson Pharma Announces FY2022 Annual Results
June 29 2022 23:20 JST
Ban Loong, Jacobson & JBM Form Joint Venture to Tap Specialty Drugs and Branded Healthcare Markets in Greater China and Asia
June 15 2022 19:56 JST
Jacobson Pharma's Chairman Uplifts Shareholding to Above 60%
March 14 2022 19:58 JST
Jacobson Pharma Announces FY2022 Interim Results
November 26 2021 19:39 JST
Jacobson Pharma Announces FY2021 Annual Results
June 29 2021 23:19 JST
JBM (Healthcare) Limited Debuts on The Main Board of SEHK
February 05 2021 16:28 JST
JBM (Healthcare) Limited to Be Spun Off from Jacobson Pharma Corporation Limited
January 25 2021 17:20 JST
Jacobson Pharma's Proposed Spin-off and Separate Listing of JBM (Healthcare) Limited on The Main Board of The Stock Exchange of Hong Kong Limited
January 15 2021 23:25 JST
Jacobson Pharma Announces FY2021 Interim Results
November 27 2020 20:10 JST
More Press release >>